These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1706439)

  • 1. Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade.
    Greskovich FJ; Johnson DE; Tenney DM; Stephenson RA
    J Urol; 1991 Apr; 145(4):798-801. PubMed ID: 1706439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of prostate-specific antigen in the diagnosis of lymphatic metastases in cancer of the prostate].
    Saad F; Bertrand P; Paquin JM; Péloquin F
    Ann Chir; 1995; 49(8):680-4. PubMed ID: 8561420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic lymph node sampling in locally advanced prostate cancer.
    Parkin J; Keeley FX; Timoney AG
    BJU Int; 2002 Jan; 89(1):14-7; discussion 17-8. PubMed ID: 11849153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
    Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
    J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.
    Winter HI; Bretton PR; Herr HW
    Urology; 1991 Sep; 38(3):202-5. PubMed ID: 1716021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer.
    Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS
    J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer.
    Arai Y; Yoshiki T; Yamabe H; Yoshida O
    Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer.
    Sands ME; Zagars GK; Pollack A; von Eschenbach AC
    Urology; 1994 Aug; 44(2):215-20. PubMed ID: 7519381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pelvic lymph node involvement in current-era prostate cancer.
    Rahman S; Cosmatos H; Dave G; Williams S; Tome M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.